Erratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443)

Torsak BunupuradahPloenchan ChetchotisakdJintanat AnanworanichWarangkana MunsakulSupunnee JirajariyavejPacharee KantipongWisit PrasithsirikulSomnuek SungkanuparphChureeratana BowonwatanuwongVirat KlinbuayaemStephen J. KerrJiratchaya SophonphanSorakij BhakeecheepBernard HirschelKiat RuxrungthamThe HIV Netherlands Australia Thailand Research CollaborationKhon Kaen UniversitySEARCHChulalongkorn UniversityBangkok Metropolitan AdministrationTaksin HospitalChiangrai Prachanukroh HospitalBamrasnaradura Infectious Disease InstituteMahidol UniversityChonburi Regional HospitalSanpatong HospitalUniversity of New South Wales (UNSW) AustraliaNational Health Security OfficeUniversite de Geneve2018-06-112018-06-112012-01-01Antiviral Therapy. Vol.17, No.7 (2012), 1389-139020402058135965352-s2.0-84870565709https://repository.li.mahidol.ac.th/handle/123456789/15122Mahidol UniversityMedicinePharmacology, Toxicology and PharmaceuticsErratum: A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: The HIV STAR study (Antiviral Therapy (2012) DOI: 10.3851/IMP2443)ErratumSCOPUS10.3851/IMP2452